M Ozdemirli
Overview
Explore the profile of M Ozdemirli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Obiorah I, Hussain A, Palese C, Azumi N, Benjamin S, Ozdemirli M
Dis Esophagus
. 2017 Sep;
30(12):1-7.
PMID: 28881885
Immunoglobulin G4 (IgG4)-related disease is a recently coined systemic disease characterized by specific histopathologic findings of an intense lymphoplasmacytic infiltrate, storiform fibrosis, and obliterative phlebitis in the presence of predominant...
2.
Obiorah I, Ozdemirli M
Transplant Proc
. 2017 Aug;
49(7):1639-1643.
PMID: 28838455
Posttransplantation lymphoproliferative disorders (PTLDs) encompass a spectrum of heterogeneous entities ranging from benign lymphocytic proliferations to high-grade malignant lymphomas. The majority of PTLDs are associated with reactivation of Epstein-Barr virus...
3.
Nassif S, Kaufman S, Vahdat S, Yazigi N, Kallakury B, Island E, et al.
Pediatr Transplant
. 2013 Oct;
17(8):765-73.
PMID: 24118781
Few studies examined the clinicopathologic features of PTLD arising in pediatric SBT patients. Particularly, the association between ATG and PTLD in this population has not been described. Retrospective review of...
4.
Tutuncuoglu S, Yanovich S, Ozdemirli M
Bone Marrow Transplant
. 2005 Jun;
36(3):265-6.
PMID: 15937503
No abstract available.
5.
Ozdemirli M, Fanburg-Smith J, Hartmann D, Azumi N, Miettinen M
Mod Pathol
. 2001 Nov;
14(11):1175-82.
PMID: 11706081
We encountered a child with an intraosseous small round cell tumor that was negative for LCA, CD20 (L26), and CD3 and positive for vimentin, CD99 (MIC-2), and periodic acid-Schiff. The...
6.
Kocazeybek B, Sonmez B, Sarman K, Sener D, Ozdemirli M, Aytekin S, et al.
Clin Microbiol Infect
. 2001 Feb;
6(11):617-8.
PMID: 11168066
No abstract available.
7.
Ratip S, Akin H, Ozdemirli M, Yucelten D, Kus S, Ekenel M, et al.
Br J Dermatol
. 2000 Aug;
143(2):450-2.
PMID: 10951166
No abstract available.
8.
Ju S, Matsui K, Ozdemirli M
Int Rev Immunol
. 2000 Feb;
18(5-6):485-513.
PMID: 10672498
Fas (CD95) and Fas ligand (FasL) are a receptor/ligand pair critically involved in lymphocyte homeostasis and peripheral tolerance such that genetic defect in either Fas or FasL results in an...
9.
Kilic G, Cardillo M, Ozdemirli M, Arun B
Eur J Gynaecol Oncol
. 1999 Jul;
20(3):167-71.
PMID: 10410876
Tumor suppressor genes p53 and Rb are important in cell cycle control. Necessity of wild type p53 is implicated in irradiation-induced apoptosis. Numerous tumor cells carry p53 mutations and yet...
10.
Ozdemirli M, Fanburg-Smith J, Hartmann D, Shad A, Lage J, Magrath I, et al.
Am J Surg Pathol
. 1998 Jul;
22(7):795-804.
PMID: 9669342
Precursor B-lymphoblastic lymphoma (B-LBL) may present as a solitary bone tumor. Fewer than 10 cases with a proven precursor B-cell phenotype have been reported in the English literature. In this...